Feb 18 (edited) • Resources and Favorites
Why We Don’t Recommend GLP-1 Medications
GLP-1 medications (Ozempic, Wegovy, Mounjaro, Tirzepatide) suppress appetite — but they do not repair the underlying causes of weight gain or metabolic disease. At Bedrock, our goal is restoration, not suppression.
What GLP-1s Do
- Suppress appetite and slow stomach emptying.
- Create short-term weight loss by eating less.
- Do NOT correct insulin resistance, inflammation, or nutrient deficiencies.
What They Don’t Fix
- Insulin resistance (the true root of metabolic disease).
- Hormone imbalance or thyroid dysfunction.
- Gut damage, nutrient depletion, or nervous system dysregulation.
Known Risks of Long-Term Use
- Delayed gastric emptying → nausea, GERD, bloating.
- Gallbladder dysfunction and bile flow impairment.
- Thyroid signaling interference.
- Muscle loss and metabolic slowdown.
- Increased anxiety in sensitive nervous systems.
Our Philosophy
We use nutrition, minerals, nervous system regulation, and metabolic repair to restore natural appetite signaling. Hunger is not the enemy — it is information.
5
1 comment
Why We Don’t Recommend GLP-1 Medications
powered by
skool.com/bedrock-nation-8489
Free wellness community for faith based living, functional health and real connection - off social media, rooted in purpose - learn, grow and heal.
Suggested communities
Powered by